NeuroPace, Inc.

NeuroPace, Inc. - Enterprise Valueverified

NPCE

Price:

$13.64

Market Cap:

$465.04M

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded...[Read more]

Industry

Medical - Devices

IPO Date

2021-04-22

Stock Exchange

NASDAQ

Ticker

NPCE

The Enterprise Value as of July 2026 (TTM) for NeuroPace, Inc. (NPCE) is 520.72M

According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 520.72M. This represents a change of 11.96% compared to the average of 465.09M of the last 4 quarters.

NeuroPace, Inc. (NPCE) Historical Enterprise Value (quarterly & annually)

How has NPCE Enterprise Value performed in the past?

The mean historical Enterprise Value of NeuroPace, Inc. over the last ten years is 314.06M. The current 520.72M Enterprise Value has changed 16.48% with respect to the historical average. Over the past ten years (40 quarters), NPCE's Enterprise Value was at its highest in in the March 2021 quarter at 594.45M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

314.06M

Median

320.87M

Minimum

99.81M

Maximum

554.38M

NeuroPace, Inc. (NPCE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeuroPace, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 221.48%

Maximum Annual Enterprise Value = 554.38M

Minimum Annual Increase = -49.61%

Minimum Annual Enterprise Value = 99.81M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025554.38M43.68%
2024385.83M20.25%
2023320.87M221.48%
202299.81M-49.61%
2021198.08M-34.76%
2020303.61M-9.59%

NeuroPace, Inc. (NPCE) Average Enterprise Value

How has NPCE Enterprise Value performed in the past?

The current Enterprise Value of NeuroPace, Inc. (NPCE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

420.36M

5-year avg

311.79M

10-year avg

314.06M

NeuroPace, Inc. (NPCE) Enterprise Value vs. Peers

How is NPCE’s Enterprise Value compared to its peers?

NeuroPace, Inc.’s Enterprise Value is less than Cerus Corporation (644.57M), greater than RxSight, Inc. (247.01M), greater than CVRx, Inc. (118.44M), greater than 908 Devices Inc. (248.71M), less than BrainsWay Ltd. (529.16M), greater than Senseonics Holdings, Inc. (216.75M), greater than Sight Sciences, Inc. (247.35M), greater than Delcath Systems, Inc. (359.35M), greater than Genelux Corporation (120.12M), greater than Aldeyra The (47.63M),

CompanyEnterprise ValueMarket cap
644.57M$575.06M
247.01M$253.76M
118.44M$131.35M
248.71M$311.81M
529.16M$555.40M
216.75M$203.54M
247.35M$290.55M
359.35M$399.76M
120.12M$126.90M
47.63M$97.12M

Build a custom stock screener for NeuroPace, Inc. (NPCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroPace, Inc. (NPCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NeuroPace, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NeuroPace, Inc. (NPCE)?

What is the 3-year average Enterprise Value for NeuroPace, Inc. (NPCE)?

What is the 5-year average Enterprise Value for NeuroPace, Inc. (NPCE)?

How does the current Enterprise Value for NeuroPace, Inc. (NPCE) compare to its historical average?